$派格生物医药-B(_老虎社区_美港股上老虎

骏马飞驰吧
08-27

$派格生物医药-B(02565)$ 经调整净亏损从 2024 年的 2.04 亿收窄至 2025 年的 0.98 亿，收窄幅度达 52%。收入增长 12 倍的同时亏损减半，经营杠杆效应显著。按照这个趋势，公司有望在 2026-2027 年实现盈亏平衡

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":601242417890640,"tweetId":"601242417890640","gmtCreate":1787824745693,"gmtModify":1787824747904,"author":{"id":4184380269673420,"idStr":"4184380269673420","authorId":4184380269673420,"authorIdStr":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":14,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 经调整净亏损从 2024 年的 2.04 亿收窄至 2025 年的 0.98 亿，收窄幅度达 52%。收入增长 12 倍的同时亏损减半，经营杠杆效应显著。按照这个趋势，公司有望在 2026-2027 年实现盈亏平衡</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 经调整净亏损从 2024 年的 2.04 亿收窄至 2025 年的 0.98 亿，收窄幅度达 52%。收入增长 12 倍的同时亏损减半，经营杠杆效应显著。按照这个趋势，公司有望在 2026-2027 年实现盈亏平衡</p></body></html>","text":"$派格生物医药-B(02565)$ 经调整净亏损从 2024 年的 2.04 亿收窄至 2025 年的 0.98 亿，收窄幅度达 52%。收入增长 12 倍的同时亏损减半，经营杠杆效应显著。按照这个趋势，公司有望在 2026-2027 年实现盈亏平衡","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/601242417890640","repostId":0,"isVote":1,"tweetType":1,"viewCount":150,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02565"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":176,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}